Laure Juompan

Randomized, Double‐Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria‐Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection

Kent E. Kester, James F. Cummings, Opokua Ofori‐Anyinam et al. · The Journal of Infectious Diseases · 2009 · 538 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A

Michele Spring, James F. Cummings, Christian F. Ockenhouse et al. · PLoS ONE · 2009 · 208 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-γ/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection

James F. Cummings, Michele Spring, Robert Schwenk et al. · Vaccine · 2009 · 88 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Structural Basis of the gp120 Superantigen-Binding Site on Human Immunoglobulins

Saoussen Karray, Laure Juompan, Rachid C. Maroun et al. · The Journal of Immunology · 1998 · 66 citations · Full text

Life Sciences, Biology, Immunology +16

Development of a cAdVax-Based Bivalent Ebola Virus Vaccine That Induces Immune Responses against both the Sudan and Zaire Species of Ebola Virus

Danher Wang, Nicholas U. Raja, Charles M. Trubey et al. · Journal of Virology · 2006 · 42 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17